Beranda › Kanker Paru Sel Kecil › Missouri › St. Louis
Uji klinis Kanker Paru Sel Kecil di St. Louis, MO
13 studi untuk Kanker Paru Sel Kecil mencari peserta di lokasi sekitar St. Louis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Menerima pesertaFase 3
- Mercy South, St Louis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Menerima pesertaFase 3
- Washington University School of Medicine, St Louis
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Menerima pesertaFase 1/2
- WA Uni School Of Med, St Louis
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Menerima pesertaFase 1
- Washington University Medicine, St Louis
Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
Menerima pesertaFase 1/2
- Washington University School of Medicine, St Louis
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Menerima pesertaFase 3
- Mercy Clinic Oncology and Hematology Sindelar Cancer Center, St Louis
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
Menerima pesertaFase 1
- Washington University School of Medicine, St Louis
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Menerima pesertaFase 1/2
- Washington University School of Medicine (Siteman Cancer Center), St Louis
A Study of LY4175408 in Participants With Advanced Cancer
Menerima pesertaFase 1
- Washington University, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Menerima pesertaFase 2
- Siteman Cancer Center, Washington University, St Louis
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Menerima pesertaFase 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Washington University, St Louis
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Washington University, St Louis
Uji klinis Kanker Paru Sel Kecil di kota lain
- Houston, TX26 studi
- Arlington, VA23 studi
- New York City, NY22 studi
- Boston, MA21 studi
- Los Angeles, CA20 studi
- Nashville, TN20 studi
- Orlando, FL15 studi
- Dallas, TX13 studi
- Cleveland, OH13 studi
- Chicago, IL13 studi
- Detroit, MI12 studi
- Washington, DC12 studi
Studi lain di St. Louis
- Kanker Paru Non-Sel Kecil73 studi
- Kanker Payudara64 studi
- Kanker Metastatik54 studi
- Kanker Kolorektal50 studi
- Kanker (semua jenis)46 studi
- Kanker Prostat46 studi
- Kanker Paru39 studi
- Kanker Ovarium38 studi
- Kanker Pankreas33 studi
- Kanker Endometrium29 studi
- Karsinoma Sel Skuamosa Kepala dan Leher28 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.